Last reviewed · How we verify

NCT03920371: BIVISTA

Evaluation of a Prototype Hand Held Hybrid Gamma Camera

Completed NA Last updated 18 April 2019
What this trial tests

NA trial testing gamma camera imaging in Tumour in 75 participants. Completed in 10 September 2018.

Timeline
13 June 2017
Primary endpoint
10 September 2018
10 September 2018

Quick facts

Lead sponsorUniversity of Leicester
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment75
Start date13 June 2017
Primary completion10 September 2018
Estimated completion10 September 2018
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Leicester

Who can join

18 and older, any sex, with Tumour. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the project is to undertake clinical development of a hybrid compact gamma camera that combines gamma ray and optical imaging. It is an extension of the previous pilot study using a newly developed handheld hybrid compact gamma camera in clinical arena.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Tumour

Currently open trials in the same condition.

Other University of Leicester trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03920371.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing